ArticleArthritis research & therapy2006

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.

Fabiola Atzeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.